Mpro inhibitor N3 (hemihydrate)
Selected Variant
HY-136149A-01
Size: 5 mg
Mpro inhibitor N3 hemihydrate is a potent inhibitor of SARS-CoV-2 Mpro with an EC50 of 16.77 μM for SARS-CoV-2. Mpro inhibitor N3 hemihydrate specifically inhibits Mpro from multiple coronaviruses, including SARS-CoV and MERS-CoV. Mpro inhibitor N3 hemihydrate displays inhibition against HCoV-229E, FIPV, and MHV-A59 with individual IC50 of 4.0 μM, 8.8 μM, and 2.7 μM, respectively[1][2].
Product Specifications
UNSPSC
12352005
Target
SARS-CoV; Virus Protease
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/mpro-inhibitor-n3-hemihydrate.html
Purity
99.86
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C([C@H](CC(C)C)NC([C@H](C(C)C)NC([C@H](C)NC(C1=NOC(C)=C1)=O)=O)=O)N[C@H](/C=C/C(OCC2=CC=CC=C2)=O)C[C@H](CCN3)C3=O.[1/2].O
Molecular Formula
C35H50N6O9
Molecular Weight
698.81
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Price
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Chromogranin A / CHGA (Neuroendocrine Marker) (CHGA/1731R), Biotin conjugate, 0.1mg/mL
P21 / WAF1 (WA-1), CF740 conjugate, 0.1mg/mL
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2576), CF647 conjugate, 0.1mg/mL
BRCA1 (Breast Marker) (BRCA1/2986), CF568 conjugate, 0.1mg/mL
Anti-Connexin 43/GJA1 Antibody Picoband®, PE Conjugate
